• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Restrictive Blood Transfusion Policies are Associated with a Lower Risk of Infection

April 9, 2014

A recent study published in JAMA adds support for the growing body of evidence recommending a restrictive red blood cell (RBC) transfusion strategy.

Rohde et al. performed a meta-analysis comparing hospital-acquired infections from 7,500 patients enrolled in 18 randomized trials.  They found rates of hospital-acquired infections were 16.9% in the liberal transfusion group and 11.8% in the conservative transfusion group (risk ratio = 0.82; 95% CI, 0.72-0.95).  When the restrictive transfusion threshold was set at less than 7.0 g/dL, the number needed to treat was 20, indicating that one patient could potentially avoid an infection out of every 20 patients treated.  The reduced risk of infection remained even among individuals who received leukocyte reduced RBCs.  More studies are needed to determine the optimal threshold for restrictive RBC transfusion strategies.

References

1. Carson JL. Blood transfusion and risk of infection: new convincing evidence. JAMA : the journal of the American Medical Association 2014; 311(13): 1293-4.

2. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA : the journal of the American Medical Association 2014; 311(13): 1317-26.

Filed Under

  • News
  • RBC Transfusion

Recommended

  • Cost-Effectiveness of Transfusions to Prevent Silent Cerebral Infarcts in Children with Sickle Cell Disease

  • Sickle Cell Trait Testing of RBC Units

  • Apheresis Lymphocyte Collections for CAR-T Cell Production Usually Well Tolerated By Cancer Patients

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • RBCs with Reduced Deformability are Removed from Circulation

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley